Agabiti-Rosei E - Search Results

1

The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study.

Lefrandt JD, Heitmann J, Sevre K, Castellano M, Hausberg M, Fallon M, Fluckiger L, Urbigkeit A, Rostrup M, Agabiti-Rosei E, Rahn KH, Murphy M, Zannad F, de Kam PJ, van Roon AM, Smit AJ. Lefrandt JD, et al. Am J Hypertens. 2001 Nov;14(11 Pt 1):1083-9. doi: 10.1016/s0895-7061(01)02218-x. Am J Hypertens. 2001. PMID: 11724204 Clinical Trial.

2

Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.

Agabiti-Rosei E, Muiesan ML, Rizzoni D, Zulli R, Calebich S, Beschi M, Castellano M, Muiesan G. Agabiti-Rosei E, et al. J Hum Hypertens. 1992 Feb;6(1):9-15. J Hum Hypertens. 1992. PMID: 1349920

3

Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related to sympathetic and renin-angiotensin-aldosterone activity.

Muiesan ML, Agabiti-Rosei E, Romanelli G, Beschi M, Castellano M, Cefis M, Cerri B, Pollavini G, Muiesan G. Muiesan ML, et al. Eur Heart J. 1992 Jan;13(1):15-21. doi: 10.1093/oxfordjournals.eurheartj.a060040. Eur Heart J. 1992. PMID: 1577025 Clinical Trial.

4

Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.

Agabiti-Rosei E, Muiesan ML, Rizzoni D, Romanelli G, Beschi M, Castellano M. Agabiti-Rosei E, et al. J Cardiovasc Pharmacol. 1991;18 Suppl 5:S5-9. J Cardiovasc Pharmacol. 1991. PMID: 1725798

5

Gene expression of catecholaminergic receptors in the central nervous system of hypertensive rats.

Castellano M, Handy DE, Beschi M, Wang YX, Agabiti-Rosei E, Gavras H. Castellano M, et al. J Hypertens Suppl. 1991 Dec;9(6):S54-5. J Hypertens Suppl. 1991. PMID: 1819011 No abstract available.

6

Plasma norepinephrine and spectral analysis of the heart rate during cardiopulmonary receptor stimulation in normal and hypertensive subjects.

Rizzoni D, Castellano M, Beschi M, Muiesan ML, Bettoni G, Porteri E, Agabiti-Rosei E. Rizzoni D, et al. J Hypertens Suppl. 1991 Dec;9(6):S84-5. J Hypertens Suppl. 1991. PMID: 1819021 No abstract available.

7

Renal and hemodynamic effects of atrial natriuretic peptide infusion are not mediated by peripheral dopaminergic mechanisms.

Castellano M, Beschi M, Agabiti-Rosei E, Rizzoni D, Rossini P, Poiesi C, Pizzocolo G, Albertini A, Muiesan G. Castellano M, et al. Am J Hypertens. 1991 Apr;4(4 Pt 1):385-8. doi: 10.1093/ajh/4.4.385. Am J Hypertens. 1991. PMID: 1829372 Clinical Trial.

8

[Hemodynamic and humoral effects of 2 different doses of ketanserin in aged patients with hypertension].

Rizzoni D, Castellano M, Beschi M, Agabiti-Rosei E. Rizzoni D, et al. Ann Ital Med Int. 1990 Oct-Dec;5(4 Pt 2):489-96. Ann Ital Med Int. 1990. PMID: 2102136 Clinical Trial. Italian.

9

Reversal of cardiac hypertrophy by long-term treatment with calcium antagonists in hypertensive patients.

Agabiti-Rosei E, Muiesan ML, Romanelli G, Beschi M, Castellano M, Muiesan G. Agabiti-Rosei E, et al. J Cardiovasc Pharmacol. 1988;12 Suppl 6:S75-8. doi: 10.1097/00005344-198812006-00019. J Cardiovasc Pharmacol. 1988. PMID: 2468913 Clinical Trial.

10

Effects of infusing alpha-atrial natriuretic peptide in primary hypertension during converting enzyme inhibition.

Agabiti-Rosei E, Castellano M, Beschi M, Muiesan ML, Romanelli G, Rizzoni D, Muiesan G. Agabiti-Rosei E, et al. J Cardiovasc Pharmacol. 1987;10 Suppl 7:S151-3. J Cardiovasc Pharmacol. 1987. PMID: 2485053 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters